MXCT vs SPCE · rev $38.6M vs rev $7.0M
MaxCyte Inc (MXCT) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
MXCT currently screens at market cap $124.3M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the MXCT and SPCE stock pages for the full models.
Not investment advice.